Matsuura N, Konishi J
Department of Pediatrics, Hokkaido University School of Medicine, Sapporo.
Endocrinol Jpn. 1990 Jun;37(3):369-79. doi: 10.1507/endocrj1954.37.369.
To define the difference in prognosis and the clinical features of transient neonatal hypothyroidism in infants born to mothers with chronic thyroiditis, we conducted a nationwide study of this condition. Sixteen mothers with chronic thyroiditis and twenty-three of their offspring with transient hypothyroidism were registered and reported in this paper. Five (group A) of twenty-two live infants showed physical, mental and/or psychomotor developmental delay (IQ below 80). No significant difference between TSH-binding inhibitor immunoglobulin (TBII) or thyroid-stimulation blocking antibody (TSBAb) activities in groups A and B (normal development) were noted. Moreover, there was no significant difference in thyroid function in the newborn period, ages at the start of thyroid medication or the dose and duration of treatment in the two groups. A striking difference observed between the two groups was the thyroid function of their mothers during pregnancy. In group A, four mothers were hypothyroid during pregnancy, and another mother discontinued thyroid medication in the last trimester and her baby was most delayed at the start thyroid medication. On the other hand, the mothers of only two of seventeen live cases in group B had mild hypothyroidism during pregnancy. There were two sets of siblings whose mother received inadequate treatment during the first pregnancy and adequate treatment during the second pregnancy. The psychomotor, physical and mental developmental delay were observed in their first babies. These findings suggested that maternal thyroid function during pregnancy might be an important factor in the prognosis of infants born to mothers with chronic thyroiditis.
为了明确慢性甲状腺炎母亲所生婴儿的短暂性新生儿甲状腺功能减退症的预后差异和临床特征,我们针对这种情况开展了一项全国性研究。本文登记并报告了16例患有慢性甲状腺炎的母亲及其23例患有短暂性甲状腺功能减退症的后代。22例存活婴儿中有5例(A组)出现身体、智力和/或精神运动发育迟缓(智商低于80)。A组和B组(发育正常)的促甲状腺素结合抑制性免疫球蛋白(TBII)或甲状腺刺激阻断抗体(TSBAb)活性无显著差异。此外,两组在新生儿期的甲状腺功能、开始甲状腺药物治疗的年龄以及治疗剂量和疗程方面均无显著差异。两组之间观察到的一个显著差异是其母亲在孕期的甲状腺功能。在A组中,4名母亲在孕期甲状腺功能减退,另一名母亲在妊娠晚期停用甲状腺药物,其婴儿在开始甲状腺药物治疗时发育延迟最为明显。另一方面,B组17例存活病例中只有2例的母亲在孕期有轻度甲状腺功能减退。有两组兄弟姐妹,其母亲在第一次怀孕时治疗不足,而在第二次怀孕时治疗充分。他们的第一个孩子出现了精神运动、身体和智力发育迟缓。这些发现表明,母亲孕期的甲状腺功能可能是慢性甲状腺炎母亲所生婴儿预后的一个重要因素。